1h Free Analyst Time
Global Rapid Influenza Diagnostic Tests Market 2020-2024Speak directly to the analyst to clarify any post sales queries you may have.
The rapid influenza diagnostic tests market is poised to grow by USD 0.89 billion during 2020-2024 progressing at a CAGR of 11% during the forecast period. This report on the rapid influenza diagnostic tests market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising demand for POCT, increasing geriatric population and government initiatives to control and prevent influenza. In addition, rising demand for POCT is anticipated to boost the growth of the market as well.
The rapid influenza diagnostic tests market analysis includes product segment and geographic landscapes
The rapid influenza diagnostic tests market is segmented as below:
By Product
- RIDTs for influenza A
- RIDTs for influenza B
By Geographic Landscapes
- North America
- Europe
- Asia
- ROW
This study identifies the rising technological advancements in diagnostics as one of the prime reasons driving the rapid influenza diagnostic tests market growth during the next few years. Also, increasing R&D investment will lead to sizable demand in the market.
The rapid influenza diagnostic tests market covers the following areas:
- Rapid influenza diagnostic tests market sizing
- Rapid influenza diagnostic tests market forecast
- Rapid influenza diagnostic tests market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading rapid influenza diagnostic tests market vendors that include Abbott Laboratories, Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Hologic Inc., Quidel Corp., Siemens Healthineers AG, and Thermo Fisher Scientific Inc.. Also, the rapid influenza diagnostic tests market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The research presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. This market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Table of Contents
Executive Summary- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
- Five Forces Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- RIDTs for influenza A - Market size and forecast 2019-2024
- RIDTs for influenza B - Market size and forecast 2019-2024
- Market opportunity by Product
Market Segmentation by End-user
- Market segments
- Comparison by End user
- Hospitals and diagnostic laboratories - Market size and forecast 2019-2024
- Academic and research centers - Market size and forecast 2019-2024
- Homecare - Market size and forecast 2019-2024
- Market opportunity by End user
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Volume drivers – Demand led growth
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Vendor landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Abbott Laboratories
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- Danaher Corp.
- F. Hoffmann-La Roche Ltd.
- Hologic Inc.
- Quidel Corp.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Key Finding 9
9: Parent market
10: Market characteristics
11: Offerings of vendors included in the market definition
12: Market segments
13: Global - Market size and forecast 2019 - 2024 ($ billion)
14: Global market: Year-over-year growth 2019 - 2024 (%)
15: Five forces analysis 2019 & 2024
16: Bargaining power of buyers
17: Bargaining power of suppliers
18: Threat of new entrants
19: Threat of substitutes
20: Threat of rivalry
21: Market condition - Five forces 2019
22: Product - Market share 2019-2024 (%)
23: Comparison by Product
24: RIDTs for influenza A - Market size and forecast 2019-2024 ($ billion)
25: RIDTs for influenza A - Year-over-year growth 2019-2024 (%)
26: RIDTs for influenza B - Market size and forecast 2019-2024 ($ billion)
27: RIDTs for influenza B - Year-over-year growth 2019-2024 (%)
28: Market opportunity by Product
29: End user - Market share 2019-2024 (%)
30: Comparison by End user
31: Hospitals and diagnostic laboratories - Market size and forecast 2019-2024 ($ billion)
32: Hospitals and diagnostic laboratories - Year-over-year growth 2019-2024 (%)
33: Academic and research centers - Market size and forecast 2019-2024 ($ billion)
34: Academic and research centers - Year-over-year growth 2019-2024 (%)
35: Homecare - Market size and forecast 2019-2024 ($ billion)
36: Homecare - Year-over-year growth 2019-2024 (%)
37: Market opportunity by End user
38: Customer landscape
39: Market share by geography 2019-2024 (%)
40: Geographic comparison
41: North America - Market size and forecast 2019-2024 ($ billion)
42: North America - Year-over-year growth 2019-2024 (%)
43: Europe - Market size and forecast 2019-2024 ($ billion)
44: Europe - Year-over-year growth 2019-2024 (%)
45: Asia - Market size and forecast 2019-2024 ($ billion)
46: Asia - Year-over-year growth 2019-2024 (%)
47: ROW - Market size and forecast 2019-2024 ($ billion)
48: ROW - Year-over-year growth 2019-2024 (%)
49: Key leading countries
50: Market opportunity by geography ($ billion)
51: Impact of drivers and challenges
52: Vendor landscape
53: Landscape disruption
54: Industry risks
55: Vendors covered
56: Market positioning of vendors
57: Abbott Laboratories - Overview
58: Abbott Laboratories - Business segments
59: Abbott Laboratories - Key offerings
60: Abbott Laboratories - Key customers
61: Abbott Laboratories - Segment focus
62: Becton, Dickinson and Co. - Overview
63: Becton, Dickinson and Co. - Business segments
64: Becton, Dickinson and Co. - Key offerings
65: Becton, Dickinson and Co. - Key customers
66: Becton, Dickinson and Co. - Segment focus
67: bioMérieux SA - Overview
68: bioMérieux SA - Business segments
69: bioMérieux SA - Key offerings
70: bioMérieux SA - Key customers
71: bioMérieux SA - Segment focus
72: Bio-Rad Laboratories Inc. - Overview
73: Bio-Rad Laboratories Inc. - Business segments
74: Bio-Rad Laboratories Inc. - Key offerings
75: Bio-Rad Laboratories Inc. - Key customers
76: Bio-Rad Laboratories Inc. - Segment focus
77: Danaher Corp. - Overview
78: Danaher Corp. - Business segments
79: Danaher Corp. - Key offerings
80: Danaher Corp. - Key customers
81: Danaher Corp. - Segment focus
82: F. Hoffmann-La Roche Ltd. - Overview
83: F. Hoffmann-La Roche Ltd. - Business segments
84: F. Hoffmann-La Roche Ltd. - Key offerings
85: F. Hoffmann-La Roche Ltd. - Key customers
86: F. Hoffmann-La Roche Ltd. - Segment focus
87: Hologic Inc. - Overview
88: Hologic Inc. - Business segments
89: Hologic Inc. - Key offerings
90: Hologic Inc. - Key customers
91: Hologic Inc. - Segment focus
92: Quidel Corp. - Overview
93: Quidel Corp. - Business segments
94: Quidel Corp. - Key offerings
95: Quidel Corp. - Key customers
96: Quidel Corp. - Segment focus
97: Siemens Healthineers AG - Overview
98: Siemens Healthineers AG - Business segments
99: Siemens Healthineers AG - Key offerings
100: Siemens Healthineers AG - Key customers
101: Siemens Healthineers AG - Segment focus
102: Thermo Fisher Scientific Inc. - Overview
103: Thermo Fisher Scientific Inc. - Business segments
104: Thermo Fisher Scientific Inc. - Key offerings
105: Thermo Fisher Scientific Inc. - Key customers
106: Thermo Fisher Scientific Inc. - Segment focus
107: Currency conversion rates for US$
108: Research Methodology
109: Validation techniques employed for market sizing
110: Information sources
111: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global rapid influenza diagnostic tests market: Abbott Laboratories, Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Hologic Inc., Quidel Corp., Siemens Healthineers AG, and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising technological advancements in diagnostics."
According to the report, one of the major drivers for this market is the rising demand for POCT.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Becton
- Dickinson and Co.
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- Danaher Corp.
- F. Hoffmann-La Roche Ltd.
- Hologic Inc.
- Quidel Corp.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
